All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

March 2009 Editor's Picks: Products from Portafab and Sterling

March 18, 2009
By Pharmaceutical Technology Editors
Article

Equipment and Processing Report

Equipment and Processing ReportEquipment and Processing Report-03-18-2009
Volume 0
Issue 0

PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the February 2009 edition from PortaFab and Sterling.

PortaFab
Cleanroom wall system accommodates wiring

The PharmaSystem cleanroom walls from PortaFab (Chesterfield, MO) have a cavity to accommodate wires, process pipes, air ducts, and chemical lines. The system also accepts structural loads for a walkable or load-bearing deck. The walls can be configured into a full enclosure with a roof. Equipment can be installed on top of the walkable ceiling if the roof of the building itself cannot support it, according to Wayne McGee, president of PortaFab.

Horizontal Z clips let clients hang the panels onto standard 3.625-in. metal-stud framework. The panels can be configured for rooms of any size or shape or used as a liner-wall system to cover existing walls. The panels have formed and cut edges to connect directly to each other and are sealed with a caulk joint, gel coat, or chemical weld. The walls are designed to provide a flush surface, inhibit bacterial growth, and control noise.

Sterling
Temperature-control units enhance water flow

The 2012 Series temperature-control units (TCUs) from Sterling (New Berlin, WI) are constructed entirely of stainless steel for washdown in pharmaceutical applications. The units’ pumps are designed according to customers’ specifications and provide high flow rates at low pressures. The products are intended to enhance water flow and temperature control.

The 2012 Series devices have an operating leaving-water temperature range of 32–250 °F. The machines are designed to hold temperatures within ±1 °F and are appropriate for gelcaps and other aqueous solutions that require tight temperature control, according to Jim Walsh, the company’s industrial products manager.

An optional cast-and-flange design reduces the product’s number of connection points and enables operators to plumb directly into the heaters. The machines feature half- and full-heat capacity and forward-facing liquid-filled “To” and “From Process” pressure gauges.

Articles in this issue

PriceFig1-586803-1408655266353.jpg
A Proactive Maintenance Approach Increases Efficiency and Reduces Costs
Sterling_2012_web-586795-1408655270898.jpg
March 2009 Editor's Picks: Products from Portafab and Sterling
The Shape of Biopharmaceutical Facilities to Come
Recent Videos
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Voucher Program Provides Shorter Drug Application Review Time

Susan Haigney
June 18th 2025
Article

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Stainless steel door and walls, clean room | Image Credit: © Alexandr - stock.adobe.com

New Company Chrysalis Launches After Acquisition of Cleanroom Assets

Patrick Lavery
June 17th 2025
Article

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.


South San Francisco, CA, USA - February 24, 2021: Closeup of a AstraZeneca building corporate office, a British-Swedish pharmaceutical, biotechnology company with its headquarters in Cambridge, England | Image Credit: © Valeriya Zankovych - stock.adobe.com

AstraZeneca Partners on AI-Enabled Research with CSPC Pharmaceuticals

Patrick Lavery
June 13th 2025
Article

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.

Related Content

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

EIT Health Ireland–UK Expands European Network with Three New Members

Patrick Lavery
June 19th 2025
Article

NIBRT, Firefinch, and eg technology will join the center, adding to its collective of healthcare innovators.


Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.


Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

FDA Voucher Program Provides Shorter Drug Application Review Time

Susan Haigney
June 18th 2025
Article

The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for shortened drug approval review time.


Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.


Stainless steel door and walls, clean room | Image Credit: © Alexandr - stock.adobe.com

New Company Chrysalis Launches After Acquisition of Cleanroom Assets

Patrick Lavery
June 17th 2025
Article

Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 pharmaceutical firms, and various other life sciences stakeholders.


South San Francisco, CA, USA - February 24, 2021: Closeup of a AstraZeneca building corporate office, a British-Swedish pharmaceutical, biotechnology company with its headquarters in Cambridge, England | Image Credit: © Valeriya Zankovych - stock.adobe.com

AstraZeneca Partners on AI-Enabled Research with CSPC Pharmaceuticals

Patrick Lavery
June 13th 2025
Article

The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule oral therapy for immunological diseases.

About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.